Remdesivir Doesn't Help

Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic

https://www.msn.com/en-us/health/medical/big-global-study-finds-remdesivir-doesn-t-help-covid-19-patients/ar-BB1a4MeV?ocid=AMZN
CNN
Big global study finds remdesivir doesn't help Covid-19 patients
By John Bonifield  1 hr ago
Feinstein's hug of Graham sparks outrage on the left
Republicans widen counterattack on Facebook and Twitter
CNN logoBig global study finds remdesivir doesn't help Covid-19 patients
In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has "little or no effect on mortality" for patients hospitalized with coronavirus and it doesn't seem to help patients recover any faster, either.

A pharmacist at AMZ Hospital in Dhaka, Bangladesh, with a generic version of remdesivi© Courtesy Dr. Ahmedul Kabir A pharmacist at AMZ Hospital in Dhaka, Bangladesh, with a generic version of remdesivi
Until now, remdesivir has been the only drug that appeared to have specific effects for coronavirus. It was the only drug with an Emergency Use Authorization for Covid-19 from the US Food and Drug Administration.

Results of the WHO study have not been published in a peer-reviewed medical journal. But WHO posted them to a pre-print server.

The WHO study reviewed remdesivir and three other repurposed drugs: hydroxychloroquine, the HIV combination of lopinavir and ritonavir and interferon. None of them helped patients live any longer or get out of the hospital any sooner, WHO said.

The trial was able to generate conclusive evidence on the impact the drugs had on mortality, the need for ventilation, and duration of hospital stay.

"For each drug in the study, the effect on mortality was disappointingly unpromising," WHO said in a statement.

Several other studies had found that hydroxychloroquine, an anti-malarial drug, was of no benefit to coronavirus patients, as had several studies looking at the HIV drug combination.

The study covered more than 11,000 coronavirus patients in 30 countries. "The protocol was designed to involve hundreds of potentially over-stressed hospitals in dozens of countries," the international team of researchers wrote. They said they have submitted their findings to a medical journal.

Prior to the WHO study, a large controlled study of remdesivir in the US found that it shortens recovery time by about a third in severely ill, hospitalized adults with Covid-19, but does little to help those with milder cases.

Gilead Sciences, the drug's maker, said the findings did not mean the drug, sold under the brand name Veklury, is of no benefit.

"The emerging data appear inconsistent with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of Veklury (remdesivir). We are concerned that the data from this open- label global trial have not undergone the rigorous review required to allow for constructive scientific discussion," Gilead said in a statement.

"The benefits of Veklury have been demonstrated in three randomized, controlled clinical trials, including a randomized, double-blind, placebo-controlled clinical trial -- the gold standard for evaluating the efficacy and safety of investigational drugs."

The WHO-led researchers say their trial, called the Solidarity trial, will continue. "Newer antiviral drugs, immunomodulators and anti-SARS COV-2 monoclonal antibodies are now being considered for evaluation via the Solidarity Therapeutics trial," WHO said.

Monoclonal antibody treatments include Regeneron's dual antibody cocktail and Eli Lilly and Co's double antibody therapy.

Author	Message Topic Search Topic Options Post Reply Create New Topic Printable Version Translate Topic
ViQueen24 Members Profile Send Private Message Find Members Posts Add to Buddy List Adviser Group Joined: May 14 2013 Location: Verona, PA Status: Offline Points: 12270	Post Options Post Reply Quote ViQueen24 Report Post Thanks(0) Quote Reply Topic: Remdesivir Doesn't Help Posted: October 15 2020 at 7:35pm
	https://www.msn.com/en-us/health/medical/big-global-study-finds-remdesivir-doesn-t-help-covid-19-patients/ar-BB1a4MeV?ocid=AMZN CNN Big global study finds remdesivir doesn't help Covid-19 patients By John Bonifield 1 hr ago Feinstein's hug of Graham sparks outrage on the left Republicans widen counterattack on Facebook and Twitter CNN logoBig global study finds remdesivir doesn't help Covid-19 patients In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has "little or no effect on mortality" for patients hospitalized with coronavirus and it doesn't seem to help patients recover any faster, either. A pharmacist at AMZ Hospital in Dhaka, Bangladesh, with a generic version of remdesivi© Courtesy Dr. Ahmedul Kabir A pharmacist at AMZ Hospital in Dhaka, Bangladesh, with a generic version of remdesivi Until now, remdesivir has been the only drug that appeared to have specific effects for coronavirus. It was the only drug with an Emergency Use Authorization for Covid-19 from the US Food and Drug Administration. Results of the WHO study have not been published in a peer-reviewed medical journal. But WHO posted them to a pre-print server. The WHO study reviewed remdesivir and three other repurposed drugs: hydroxychloroquine, the HIV combination of lopinavir and ritonavir and interferon. None of them helped patients live any longer or get out of the hospital any sooner, WHO said. The trial was able to generate conclusive evidence on the impact the drugs had on mortality, the need for ventilation, and duration of hospital stay. "For each drug in the study, the effect on mortality was disappointingly unpromising," WHO said in a statement. Several other studies had found that hydroxychloroquine, an anti-malarial drug, was of no benefit to coronavirus patients, as had several studies looking at the HIV drug combination. The study covered more than 11,000 coronavirus patients in 30 countries. "The protocol was designed to involve hundreds of potentially over-stressed hospitals in dozens of countries," the international team of researchers wrote. They said they have submitted their findings to a medical journal. Prior to the WHO study, a large controlled study of remdesivir in the US found that it shortens recovery time by about a third in severely ill, hospitalized adults with Covid-19, but does little to help those with milder cases. Gilead Sciences, the drug's maker, said the findings did not mean the drug, sold under the brand name Veklury, is of no benefit. "The emerging data appear inconsistent with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals validating the clinical benefit of Veklury (remdesivir). We are concerned that the data from this open- label global trial have not undergone the rigorous review required to allow for constructive scientific discussion," Gilead said in a statement. "The benefits of Veklury have been demonstrated in three randomized, controlled clinical trials, including a randomized, double-blind, placebo-controlled clinical trial -- the gold standard for evaluating the efficacy and safety of investigational drugs." The WHO-led researchers say their trial, called the Solidarity trial, will continue. "Newer antiviral drugs, immunomodulators and anti-SARS COV-2 monoclonal antibodies are now being considered for evaluation via the Solidarity Therapeutics trial," WHO said. Monoclonal antibody treatments include Regeneron's dual antibody cocktail and Eli Lilly and Co's double antibody therapy.

Dutch Josh Members Profile Send Private Message Find Members Posts Add to Buddy List Adviser Group Joined: May 01 2013 Location: Arnhem-Netherla Status: Offline Points: 95217	Post Options Post Reply Quote Dutch Josh Report Post Thanks(0) Quote Reply Posted: October 16 2020 at 12:36am
	Maybe it is time to nationalize big pharma so profit does not stay a leading principle in medication...I believe zinc, viamins can make a lot of difference in prevention. The earlier the treatment the better....you should not make profit out of a pandemic !
	We cannot solve our problems with the same thinking we used when we created them. ~Albert Einstein

EdwinSm, Members Profile Send Private Message Find Members Posts Add to Buddy List Moderator Joined: April 03 2013 Status: Offline Points: 24065	Post Options Post Reply Quote EdwinSm, Report Post Thanks(1) Quote Reply Posted: October 16 2020 at 3:43am
	Link to full report: https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1.full.pdf What is interesting is that this was a study in "real life" hospital situations rather than in a controlled setting (that allowed the pharm company's own test to show it worked). Maybe it will still be of benefit in say teaching hospitals in the rich countries if they are not overwhelmed but other cases.